Skip to the page content
Your donations
Passes our checks

International Bladder Cancer Group

EIN 93-2407167 · Flemington, NJ

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong93 out of 100GovernanceWeak22 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

The International Bladder Cancer Group (IBCG) is a globally recognized entity that has published numerous peer-reviewed articles addressing knowledge gaps in - and providing recommendations for - the management of bladder cancer.The IBCG was formed with a primary objective being to address global educational needs and learning gaps in order to improve the care and management of patients with urothelial carcinoma. The inaugural meeting, in 2006, consisted of members selected as representatives of their varied geographic regions across Europe, North America and Asia. The members were specifically selected not only for their expertise but also to ensure representation from across the globe.Over the years, the mission of the IBCG has been to improve outcomes of patients suffering from bladder cancer through critical evaluation and leveraging of existing data to drive evidence-based treatment. An additional goal is to develop practical educational tools that are applicable to the global uro

Income
$603,104
Spending
$436,909
Spent on programs
98%
Reserves
6.8 months of spending
Largest source of income
donations and private grants, 100%
Employees
0

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 93 out of 100. Higher than 68% of charities in its peer group (medical research, $250k to $1m).

  • Reserves

    28 of 35

    Spendable reserves would cover 6.8 months of spending.

  • Debt

    20 of 20

    It owes 0% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 28% of income.

  • Income trend

    15 of 15

    Income rose 54% on the year before.

  • Spending floor

    15 of 15

    98% of spending went to programs and raising each dollar of donations cost 0 cents.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Weak: 22 out of 100. Higher than 2% of charities in its peer group (medical research, $250k to $1m).

  • Independent board

    5 of 25

    0 of 3 voting board members are independent.

  • Conflict of interest policy

    0 of 15

    Reports no written conflict of interest policy.

  • Whistleblower policy

    0 of 8

    Reports no written whistleblower policy.

  • Record keeping policy

    0 of 7

    Reports no written policy on keeping and destroying records.

  • Board minutes

    0 of 5

    Reports that it does not keep minutes of board meetings.

  • Board sees the tax return

    0 of 10

    Did not give the board a copy of this return before filing it.

  • Independent check of accounts

    6 of 15

    Its accounts were not audited or reviewed by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $429,066 spent. The IBCG has expanded its membership in the past few years to include many globally recognized experts in the field of bladder cancer. This expansion has included a wide range of health care professionals including medical oncologists, radiation oncologists, statisticians and researchers with representation to include all the continents. In 2021, the IBCG created a Health Services Research group led by Dr. Stephen B Williams which aims to be the collaborative source for clinicians and researchers. An IBCG newsletter under Chief Editor Dr. Fred Witjes was launched in Q1 2022. In August 2025, the IBCG held a retreat (#IBCG25) to discuss 2 very important topics: Biomarkers in Urothelial CancerToxicity of Local Therapies for Bladder CancerThis retreat led by our program chairs, Drs. Shilpa Gupta, Roger Li, and Patrick Hensley opened its doors to a wider audience with partners from industry invited to join the KOLs and patient advocates, and resulted in robust discussions directed towards improving care for our patients. Other activities include: AUA - IBCG Bladder Cancer Forum - held in 2022 ,2023, 2024 and 2025; IBCG collaboration with Mexican Urological Society to develop Mexican Bladder Cancer Guidelines; Collaborative effort between GSRGT and IBCG to tackle variant histology/histologic subtypes in bladder cancer. The IBCG will continue to support ongoing initiatives including clinical trial design, clinical research, national and international guideline assistance, and conference or symposium organization.

Source: Form 990 for the year ending December 31, 2025, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2025.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since April 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.